Therapy News and Research

RSS

mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants

Researchers assess the efficacy of monoclonal antibodies in treating COVID-19 caused by different viral variants.

6 Apr 2023

Exploring the gut microbiome's role in rheumatoid arthritis pathogenesis

Researchers analyzed data on the association between intestinal microbiome dysbiosis and rheumatoid arthritis.

6 Apr 2023

Revolution in MDR-TB treatment: Shorter all-oral regimens

Researchers reported on the evolution of multidrug-resistant tuberculosis (MDR-TB) therapy.

6 Apr 2023

Can fecal microbiota be administered safely and efficiently to prevent Clostridiodes difficile infection?

Researchers assessed the safety and efficacy of fecal microbiota in preventing Clostridiodes difficile infection.

6 Apr 2023

Using brain organoids to test gene therapies for a rare disease in children

Brain tissue grown in a laboratory by University of Queensland researchers will be used to test a treatment for a rare disease in children and help unlock therapies for a range of neurological disorders.

5 Apr 2023

Childhood cancer survivors maintaining a healthy lifestyle may have lower risk of mortality

A report from the Childhood Cancer Survivor Study provides strong evidence of the importance of a healthy lifestyle for adults who were treated for cancer as children.

5 Apr 2023

Complex assembly process involved in DNA virus replication revealed

In a twist on the question, "Which came first, the chicken or the egg?", scientists have long faced a similar question about how human adenovirus replicates: "Which comes first, assembly of the viral particle, or packaging of the viral genome?"

5 Apr 2023

IU study sheds new light on the development and treatment of rare form of muscular dystrophy

A study by Indiana University School of Medicine researchers sheds new light on the development and treatment of a rare form of muscular dystrophy.

5 Apr 2023

Promising new combination of drugs identified to treat juvenile myelomonocytic leukemia

Indiana University School of Medicine researchers have identified a promising new combination of drugs to treat juvenile myelomonocytic leukemia (JMML), a rare form of blood cancer that affects children.

5 Apr 2023

Exposure therapy could be a promising treatment for adolescents with eating disorders

Whether you're afraid of dogs, needles or enclosed spaces, one of the most effective interventions for this type of anxiety disorder is exposure therapy in which you confront your fear in a safe environment.

5 Apr 2023

Novel combination treatment for head and neck cancers leads to antitumor effects

Human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) and lung cancer can have disruptive mutations in TP53and/or CDKN2A tumor suppressor genes, which are associated with poor patient survival.

5 Apr 2023

Study explains why leukemia survivors experience negative effects on blood formation decades later

Contrary to previous belief, stem cells, from which all new blood cells are formed, remain in bone marrow in the blood cancer type acute lymphocytic leukemia.

5 Apr 2023

Study reveals the potential cost savings of a therapy for babies displaying early signs of autism

New research evaluating the potential cost savings of a therapy for babies displaying early autism signs has predicted a three dollar return to Australia's National Disability Insurance Scheme (NDIS) for every dollar invested in therapy.

5 Apr 2023

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

The scientific foundation needed to work on curing a class of cancer-causing mutations is here, in the form of a tool from St. Jude Children's Research Hospital.

5 Apr 2023

New imaging technique can improve the treatment of intestinal strictures in Crohn's disease

Patients suffering from Crohn's disease, a chronic inflammatory intestinal disorder, develop painful constrictions in the bowel.

5 Apr 2023

Antioxidant supplementation shows potential to improve male fertility

A new study discusses the benefits of antioxidant supplementation on male fertility.

4 Apr 2023

Computational model of the cardiovascular system for predicting and preventing aortic ruptures

An abdominal aortic aneurysm (AAA) causes the wall of a person's aorta, the largest artery in the body, to weaken and bulge outward. If left untreated, it can continue to grow and eventually rupture, which can lead to life-threatening bleeding.

4 Apr 2023

Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children's Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.

4 Apr 2023

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.

4 Apr 2023

Research provides new insights into the underlying disease mechanisms for polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal genetic disease - about a half million people in the United States alone suffer from the condition.

4 Apr 2023

Therapy News and Research

mAb therapy reduces risk of hospitalization and death against Alpha, Delta, and Omicron variants

Exploring the gut microbiome's role in rheumatoid arthritis pathogenesis

Revolution in MDR-TB treatment: Shorter all-oral regimens

Can fecal microbiota be administered safely and efficiently to prevent Clostridiodes difficile infection?

Using brain organoids to test gene therapies for a rare disease in children

Childhood cancer survivors maintaining a healthy lifestyle may have lower risk of mortality

Complex assembly process involved in DNA virus replication revealed

IU study sheds new light on the development and treatment of rare form of muscular dystrophy

Promising new combination of drugs identified to treat juvenile myelomonocytic leukemia

Exposure therapy could be a promising treatment for adolescents with eating disorders

Novel combination treatment for head and neck cancers leads to antitumor effects

Study explains why leukemia survivors experience negative effects on blood formation decades later

Study reveals the potential cost savings of a therapy for babies displaying early signs of autism

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

New imaging technique can improve the treatment of intestinal strictures in Crohn's disease

Antioxidant supplementation shows potential to improve male fertility

Computational model of the cardiovascular system for predicting and preventing aortic ruptures

Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Research provides new insights into the underlying disease mechanisms for polycystic kidney disease

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News